Back
Givaudan SA Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
82
GVDNY
Givaudan SA
Last Price:
$98.03
Seasonality Move:
4.12%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
$38.82
Seasonality Move:
2.85%
Buy
82
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $99.17. The Score for GVDNY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $40.05. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $99.17The current trend is moderately bullish and GVDNY is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $40.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
GVDNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.84 | Buy |
Relative Strength Index (14 RSI): | 64.36 | Buy |
Chaikin Money Flow: | -8606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.13 - 98.05) | Buy |
Bollinger Bands (100): | (85.52 - 93.86) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.04 | Sell |
Relative Strength Index (14 RSI): | 33.73 | Sell |
Chaikin Money Flow: | -8069571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.85 - 60.79) | Sell |
Bollinger Bands (100): | (56.32 - 117.26) | Sell |
GVDNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.97 | Buy |
20-day SMA: | 96.45 | Buy |
50-day SMA: | 92.04 | Buy |
200-day SMA: | 93.44 | Buy |
8-day EMA: | 97.82 | Buy |
20-day EMA: | 96.13 | Buy |
50-day EMA: | 93.3 | Buy |
200-day EMA: | 91.18 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.25 | Buy |
20-day SMA: | 47.56 | Sell |
50-day SMA: | 59.29 | Sell |
200-day SMA: | 106.93 | Sell |
8-day EMA: | 39.29 | Buy |
20-day EMA: | 45.05 | Sell |
50-day EMA: | 59.91 | Sell |
200-day EMA: | 95.91 | Sell |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.
Givaudan SA Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |